LimFlow Announces Presentation of the LimFlow Procedure at a Dedicated Symposium During the Leipzig Interventional Course, LINC 2015 – January 27-30, 2015

Dresden Germany 15 December 2014 — LimFlow today announced that Drs. Andrej Schmidt and Jihad Mustapha will be chairing a session on the LimFlow procedure for treating Critical Limb Ischemia at the upcoming Leipzig Interventional Course or LINC on Tuesday 27 January 2015 starting at 16:00 CET (www.leipzig-interventional-course.com) .

Download a schedule of the talks.

About LimFlow GmbH
LimFlow is a private, venture-backed medical device company offering a novel therapeutic to treating Critical Limb Ischemia. LimFlow is enrolling patients into its feasibility clinical study using its patented Percutaneous Deep Vein Arterialization in Singapore and Leipzig Germany with its CE Mark trial to being in early 2015.

By | 2017-08-28T23:22:12+00:00 December 15th, 2014|